Literature DB >> 24922189

Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma.

Ekaterina Pisareva1, Nadezhda Gutkina, Sergei Kovalenko, Sarah Kuehnapfel, Arndt Hartmann, Lucie Heinzerling, Regine Schneider-Stock, Lyudmila Lyubchenko, Vladimir A Shamanin.   

Abstract

Mutations at BRAF codon V600 are used as predictive biomarkers for targeted therapy of skin melanoma. Here, a simple sensitive test to detect mutations of BRAF-V600 was developed using real-time PCR with allele-specific primers and TaqMan probes. Two versions of the test using sense and antisense allele-specific primers were designed and evaluated. The test detected 1% mutant allele V600E/K in 10 ng DNA standard made from wild-type human DNA spiked with BRAF-V600E or the V600K plasmid. The test was validated on clinical formalin-fixed paraffin-embedded samples of skin melanoma using pyrosequencing as a reference method. In the clinical samples, we detected the common mutation V600E, as well as the rare mutations V600K, V600E2 (codon GAA), V600E2 K601del, V600D-K601del, and V600R. In comparison with pyrosequencing, both versions of the test had 100% specificity with sensitivities of 97 and 86% for sense and antisense allele-specific primers, respectively. Using the PCR test with sense allele-specific primers, mutations in V600 were found in 33 of 51 Russian patients (64.7%) with cutaneous melanoma. This closed-tube real-time PCR test can be used as a simple and sensitive assay for mutations of BRAF-V600 in cutaneous melanoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24922189     DOI: 10.1097/CMR.0000000000000090

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  1 in total

1.  Validation of an NGS mutation detection panel for melanoma.

Authors:  Anne Reiman; Hugh Kikuchi; Daniela Scocchia; Peter Smith; Yee Wah Tsang; David Snead; Ian A Cree
Journal:  BMC Cancer       Date:  2017-02-22       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.